Henry Schein, Inc. (NASDAQ: HSIC), the leading provider of healthcare solutions for dental and medical practices, has added three new members to its Executive Management Committee (EMC). Steve Boggan and Bianka Wilson, who have been appointed Co-CEOs of the Global Oral Reconstruction Group (GORG), along with Tom Popeck, CEO of the Healthcare Specialties Group (HSG), join the committee.
GORG encompasses Henry Schein’s premium implant lines and biomaterial products, while HSG includes manufacturing brands in endodontic, orthodontic, and orthopedic markets.
Stanley Bergman, Chairman and CEO of Henry Schein, Inc., expressed delight in welcoming three accomplished leaders to the company’s Executive Management Committee. Steve Boggan, Bianka Wilson, and Tom Popeck have demonstrated excellence in navigating the evolving global healthcare landscape.
The strategic plan BOLD+1 is advanced through GORG and HSG, focusing on expanding higher-growth and higher-margin specialty offerings. These businesses strengthen customer relationships alongside distribution, software, and value-added services.
Mr. Boggan, who joined Henry Schein in 2013 through the BioHorizons acquisition, will oversee commercial operations in the Americas and the Middle East as Co-CEO of GORG. Ms. Wilson, with over 25 years of finance and consulting experience, will lead strategy and finance for GORG’s European and APAC operations. Mr. Popeck, who joined in 2019, brings over 20 years of sales leadership, overseeing HSG since 2023.
